Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
9.53
-0.03 (-0.31%)
Mar 31, 2025, 4:00 PM EDT - Market closed
Indivior Employees
As of December 31, 2024, Indivior had 1,051 total employees, including 1,030 full-time and 21 part-time employees. The number of employees decreased by 113 or -9.71% compared to the previous year.
Employees
1,051
Change (1Y)
-113
Growth (1Y)
-9.71%
Revenue / Employee
$1,130,352
Profits / Employee
-$45,671
Market Cap
1.17B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
INDV News
- 27 days ago - Indivior Announces Further Changes to Board of Directors - PRNewsWire
- 4 weeks ago - UK's Indivior appoints Joe Ciaffoni as CEO - Reuters
- 4 weeks ago - Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer - PRNewsWire
- 5 weeks ago - Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection - PRNewsWire
- 5 weeks ago - Indivior PLC (INDV) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat - Benzinga
- 5 weeks ago - UK's Indivior forecasts 17% decline in 2025 revenue - Reuters
- 5 weeks ago - Indivior Announces FY and Q4 2024 Financial Results - PRNewsWire